Delivery Order SPE2DB20D1050-SPE2DB25FH62M
- Not listed
- AmerisourceBergen Drug Corp was awarded a Delivery Order valued at $27,194.41 by the Defense Logistics Agency (DLA) on May 6, 2025, for the supply of Miebo 100% eye drop (3mL) with an ultimate completion date of May 7, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a $3,202.62 delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Miebo 100% eye drop medication in 3ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the company's existing contract...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,256.76 for MIEBO 100% eye drop supply (3ml units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Miebo 100% eye drops (3 mL), with a ceiling value of $18,826.55. The contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,458.02 by the Medical Supply Chain, a defense-focused federal agency, on September 29, 2025, for the supply of Miebo 100% eye drop medication in 3ML units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $7,203.58 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for MIEBO 100% eye drops (3ML). This is a firm fixed-price, competitively awarded contract with a completion date of July 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,897.98 for Miebo 100% eye drop (3mL) under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Miebo 100% eye drops in 3ml units, valued at $8,033.24. This firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled for completion by July...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH62MDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,597.08 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Miebo 100% eye drops in 3ml units. The award is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of April 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical products to support federal military and veteran healthcare systems. The parent IDC contract serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for ophthalmic medication reflects the company's ongoing role in fulfilling critical medical supply needs for the Department of Defense through the DLA's procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 4/24/25 |